Baseline anxiety disorders are associated with progression of diabetic kidney disease in type 2 diabetes

References

• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188.
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37(10):2864–2883.
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308.
   PubMed Web of Science ®Google Scholar
• Maqbool M, Cooper ME, Jandeleit-Dahm KAM. Cardiovascular disease and diabetic kidney disease. Semin Nephrol. 2018;38(3):217–232.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Beland M, Clyde M, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99.
   PubMed Web of Science ®Google Scholar
• Weaver LJ, Madhu SV. Type 2 diabetes and anxiety symptoms among women in New Delhi, India. Am J Public Health. 2015;105(11):2335–2340.
   PubMed Web of Science ®Google Scholar
• de Groot M, Golden SH, Wagner J. Psychological conditions in adults with diabetes. Am Psychol. 2016;71(7):552–562.
   PubMed Web of Science ®Google Scholar
• Ranjan R, Nath S, Sarkar S. Association between depression, anxiety and quality of life among patients with diabetes mellitus and/or hypertension in a tertiary care railway hospital in India: a cross-sectional study. Indian J Psychiatry. 2020;62(5):555–558.
   PubMed Web of Science ®Google Scholar
• Iturralde E, Chi FW, Grant RW, et al. Association of anxiety with high-cost health care use among individuals with type 2 diabetes. Diabetes Care. 2019;42(9):1669–1674.
   PubMed Web of Science ®Google Scholar
• Whitworth SR, Bruce DG, Starkstein SE, et al. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: the Fremantle diabetes study phase II. Diabetes Res Clin Pract. 2016;122:190–197.
   PubMed Web of Science ®Google Scholar
• Naicker K, Johnson JA, Skogen JC, et al. Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. Diabetes Care. 2017;40(3):352–358.
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Beekman AT, de Jonge P, et al. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):e249.
   PubMedGoogle Scholar
• Aggarwal HK, Jain D, Dabas G, et al. Prevalence of depression, anxiety and insomnia in chronic kidney disease patients and their co-relation with the demographic variables. Prilozi. 2017;38(2):35–44.
   PubMedGoogle Scholar
• Hu S, Li Y, Quan M, et al. A study on the correlations of anxiety and depression with self-management ability and endogenous creatinine clearance rate in renal transplant recipients. Front Psychiatry. 2021;12:715509.
   PubMed Web of Science ®Google Scholar
• Bai R, Liu S, Zhao Y, et al. Depressive and anxiety disorders in systemic lupus erythematosus patients without major neuropsychiatric manifestations. J Immunol Res. 2016;2016:1–7.
   Web of Science ®Google Scholar
• Kurki T, Hiilesmaa V, Raitasalo R, et al. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95(4):487–490.
   PubMed Web of Science ®Google Scholar
• Huang CW, Wee PH, Low LL, et al. Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;69:27–40.
   PubMed Web of Science ®Google Scholar
• Brenes GA, Guralnik JM, Williamson JD, et al. The influence of anxiety on the progression of disability. J Am Geriat Soc. 2005;53(1):34–39.
   PubMed Web of Science ®Google Scholar
• Li XX, Li Z. The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2018;33(1):131–140.
   PubMed Web of Science ®Google Scholar
• Paterniti S, Zureik M, Ducimetiere P, et al. Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21(1):136–141.
   PubMed Web of Science ®Google Scholar
• Jiang L, Atasoy S, Johar H, et al. Anxiety boosts progression of prediabetes to type 2 diabetes: findings from the prospective cooperative health research in the region of Augsburg F4 and FF4 studies. Diabet Med. 2020;37(10):1737–1741.
   PubMed Web of Science ®Google Scholar
• Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol. 2007;49(20):2021–2027.
   PubMed Web of Science ®Google Scholar
• Jia W, Weng J, Zhu D, Chinese Diabetes Society, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.
   PubMed Web of Science ®Google Scholar
• Stern AF. The hospital anxiety and depression scale. Occup Med. 2014;64(5):393–394.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
   PubMed Web of Science ®Google Scholar
• Sukkar L, Kang A, Hockham C, EXTEND45 Study Steering Committee, et al. Incidence and associations of chronic kidney disease in community participants with diabetes: a 5-year prospective analysis of the EXTEND45 study. Diabetes Care. 2020;43(5):982–990.
   PubMed Web of Science ®Google Scholar
• Castellano-Guerrero AM, Guerrero R, Relimpio F, et al. Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol. 2018;55(9):943–953.
   PubMed Web of Science ®Google Scholar
• Jacobsen P, Tarnow L, Carstensen B, et al. Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol. 2003;14(11):2843–2850.
   PubMed Web of Science ®Google Scholar
• Victor P, Umapathy D, George L, et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. Cell Stress Chaperones. 2021;26(2):311–321.
   PubMed Web of Science ®Google Scholar
• Hassan W, Silva CE, Mohammadzai IU, et al. Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol. 2014;12(2):120–139.
   PubMed Web of Science ®Google Scholar
• Smaga I, Niedzielska E, Gawlik M, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569–580.
   PubMed Web of Science ®Google Scholar
• Balthazar L, Lages YVM, Romano VC, et al. The association between the renin-angiotensin system and the hypothalamic-pituitary-adrenal axis in anxiety disorders: a systematic review of animal studies. Psychoneuroendocrinology. 2021;132:105354.
   PubMed Web of Science ®Google Scholar
• Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5(3):393–398.
   PubMedGoogle Scholar
• Kelly KJ, Burford JL, Dominguez JH. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;297(4):F923–931.
   PubMed Web of Science ®Google Scholar
• Shao BY, Zhang SF, Li HD, et al. Epigenetics and inflammation in diabetic nephropathy. Front Physiol. 2021;12:649587.
   PubMed Web of Science ®Google Scholar
• Lee AK, Lee CJ, Huang ES, et al. Risk factors for severe hypoglycemia in black and white adults with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2017;40(12):1661–1667.
   PubMed Web of Science ®Google Scholar
• Wu CS, Hsu LY, Pan YJ, et al. Associations between antidepressant use and advanced diabetes outcomes in patients with depression and diabetes mellitus. J Clin Endocrinol Metab. 2021;106(12):e5136–e5146.
   PubMed Web of Science ®Google Scholar